A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/36 (2006.01) A61K 9/22 (2006.01) A61K 31/135 (2006.01) A61K 31/165 (2006.01) A61K 31/496 (2006.01)
Patent
CA 2616204
The invention relates to a sustained release formulation for delivering one or more pharmaceutically active agents The formulation comprises cross-linked high amylose starch and at least one pharmaceutically active agent, and, when subdivided into smaller dosage forms, the smaller dosage forms have substantially the same sustained release properties as the formulation from which they were derived The formulations can provide sustained release for up to at least 24 hours, and because of their divisability permits a recipient of the active agent or the person administering the active agent to titrate the dosage of the agent.
L'invention concerne une formulation à libération prolongée destinée à l'administration d'un ou plusieurs agents pharmaceutiques actifs. Ladite formulation contient de l'amidon réticulé à forte teneur en amylose et au moins un agent pharmaceutique actif, et peut éventuellement être fractionnée en formes posologiques plus petites présentant les mêmes propriétés de libération prolongée que la formulation dont elles dérivent. Les formulations peuvent présenter une libération prolongée sur 24 heures, et permettent un dosage de l'agent actif du fait de leur fractionnabilité.
Contamin Pauline
Gervais Sonia
Ma My Linh
Ouzerourou Rachid
Smith Damon
Labopharm (barbados) Limited
Labopharm Europe Limited
Labopharm Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Sustained drug release composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained drug release composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained drug release composition will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1505689